Literature DB >> 9648972

Pulmonary vascular disorders in portal hypertension.

P Hervé1, D Lebrec, F Brenot, G Simonneau, M Humbert, O Sitbon, P Duroux.   

Abstract

The wide spectrum of pulmonary vascular disorders in liver disease and portal hypertension ranges from the hepatopulmonary syndrome characterized by intrapulmonary vascular dilatations, to pulmonary hypertension (portopulmonary hypertension), in which pulmonary vascular resistance is elevated. Since hepatopulmonary syndrome and portopulmonary hypertension have been reported in patients with nonhepatic portal hypertension, the common factor that determines their development must be portal hypertension. The clinical presentations are very different, with gas exchange impairment in the hepatopulmonary syndrome and haemodynamic failure in portopulmonary hypertension. The severity of hepatopulmonary syndrome seems to parallel the severity of liver failure, whereas no simple relationship has been identified between hepatic impairment and the severity of portopulmonary hypertension. Resolution of hepatopulmonary syndrome is common after liver transplantation, which has an uncertain effect in portopulmonary hypertension. The pathophysiology of both syndromes may involve vasoactive mediators and angiogenic factors.

Entities:  

Mesh:

Year:  1998        PMID: 9648972     DOI: 10.1183/09031936.98.11051153

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  49 in total

Review 1.  Primary pulmonary hypertension.

Authors:  A J Peacock
Journal:  Thorax       Date:  1999-12       Impact factor: 9.139

2.  Hepatopulmonary syndromes.

Authors:  M J Krowka
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

3.  Effects of terlipressin on systolic pulmonary artery pressure of patients with liver cirrhosis: an echocardiographic assessment.

Authors:  Engin Altintas; Necdet Akkus; Ramazan Gen; M-Rami Helvaci; Orhan Sezgin; Dilek Oguz
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

Review 4.  CT imaging of peripheral pulmonary vessel disease.

Authors:  Arnaud Resten; Sophie Maitre; Dominique Musset
Journal:  Eur Radiol       Date:  2005-05-20       Impact factor: 5.315

Review 5.  The extrahepatic consequences of cirrhosis.

Authors:  Jin Kee Ho; Eric Yoshida
Journal:  MedGenMed       Date:  2006-03-02

Review 6.  Portopulmonary hypertension.

Authors:  Michael Halank; Ralf Ewert; Hans-Juergen Seyfarth; Gert Hoeffken
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

7.  Portopulmonary hypertension.

Authors:  Ravi P Nayak; Dechun Li; George M Matuschak
Journal:  Curr Gastroenterol Rep       Date:  2009-02

8.  Effects of caffeic acid phenethyl ester (CAPE) on hepatopulmonary syndrome.

Authors:  Ahmet Tekin; Serdar Türkyılmaz; Tevfik Küçükkartallar; Murat Cakır; Hüseyin Yılmaz; Hasan Esen; Burhan Ateş; Ilhan Ciftci; Adil Kartal
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

9.  Hepatopulmonary syndrome: the role of intra-abdominal hypertension and a novel mouse model.

Authors:  Zhaojie Zhang; Xiaolong Qi; Zhiwei Li; Lijun Xu; Fei Wang; Shenglan Wang; Yizhong Chang; Wanrong Ma; Mingxin Xu; Changqing Yang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

10.  Regression of pulmonary vascular disease after therapy of Abernethy malformation in visceral heterotaxy.

Authors:  Krishnan A Raghuram; Sasidharan Bijulal; Kavasseri M Krishnamoorthy; Jaganmohan A Tharakan
Journal:  Pediatr Cardiol       Date:  2012-07-28       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.